aTyr Pharma Net Income 2024

aTyr Pharma Net Income

-51.01 M USD

aTyr Pharma Dividend yield

Ticker

LIFE

ISIN

US0021202025

WKN

A2PM86

In 2024, aTyr Pharma's profit amounted to -51.01 M USD, a 1.23% increase from the -50.39 M USD profit recorded in the previous year.

The aTyr Pharma Net Income history

YEARNET INCOME (undefined USD)
2029e288.5
2028e168.59
2027e51.52
2026e-10.45
2025e-56.86
2024e-51.01
2023-50.39
2022-45.34
2021-33.77
2020-16.22
2019-23.6
2018-34.52
2017-48.21
2016-57.86
2015-47.99
2014-24.77
2013-21.65
2012-17.61

aTyr Pharma Aktienanalyse

What does aTyr Pharma do?

aTyr Pharma Inc is a biotechnology company based in San Diego, California. Founded in 2005, the company has gained a lot of attention in recent years for its focus on developing drugs based on proteomics, the analysis of proteins. The idea for aTyr came from the realization that there are a variety of proteins that can be used as a basis for developing new drugs. The company has developed a unique proteomics platform that allows for the identification and utilization of previously undiscovered proteins to understand biological processes and develop new drugs for diseases. aTyr specializes in the discovery and development of proteins associated with rare but difficult-to-treat diseases. This includes rare muscle diseases and lung diseases. The company collaborates closely with clinicians and scientists to advance its research and development. aTyr's business model is based on the development of new drugs based on proteomics, with a focus on rare diseases that are often neglected. The goal is to improve the quality of life for patients by developing new and innovative drugs. aTyr has various divisions, including therapeutic proteins and diagnostics. The company has a number of drugs in development targeting different diseases. This includes Resolaris, a protein focused on rare muscle diseases, and ATYR1923, developed for the treatment of lung diseases. Resolaris is a novel protein targeting rare muscle diseases such as FSHD and LGMD. It is currently being tested in clinical trials and has the potential to significantly improve the quality of life for patients with these severe conditions. The company is also developing ATYR1923, a protein for the treatment of lung diseases such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Overall, aTyr Pharma is an innovative company focused on the development of novel drugs based on proteomics. With its unique proteomics platform, the company has the potential to identify and utilize previously undiscovered proteins to understand biological processes and develop new drugs for diseases. With its various divisions, including therapeutic proteins and diagnostics, the company has the potential to improve the treatment of rare and difficult-to-treat diseases and enhance the lives of patients worldwide. aTyr Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding aTyr Pharma's Profit Margins

The profit margins of aTyr Pharma represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of aTyr Pharma's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating aTyr Pharma's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

aTyr Pharma's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When aTyr Pharma’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about aTyr Pharma Stock

How much profit has aTyr Pharma made this year?

aTyr Pharma has made -51.01 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 1.23% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does aTyr Pharma publish its earnings?

aTyr Pharma publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of aTyr Pharma?

The profits of aTyr Pharma are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of aTyr Pharma?

You can learn more about the earnings of aTyr Pharma by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does aTyr Pharma pay?

Over the past 12 months, aTyr Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, aTyr Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of aTyr Pharma?

The current dividend yield of aTyr Pharma is .

When does aTyr Pharma pay dividends?

aTyr Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of aTyr Pharma?

aTyr Pharma paid dividends every year for the past 0 years.

What is the dividend of aTyr Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is aTyr Pharma located?

aTyr Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von aTyr Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of aTyr Pharma from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did aTyr Pharma pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of aTyr Pharma in the year 2023?

In the year 2023, aTyr Pharma distributed 0 USD as dividends.

In which currency does aTyr Pharma pay out the dividend?

The dividends of aTyr Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The aTyr Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von aTyr Pharma

Our stock analysis for aTyr Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of aTyr Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.